Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study
- 12 August 2003
- journal article
- clinical trial
- Published by Springer Nature in Pediatric Nephrology
- Vol. 18 (10) , 1015-1019
Abstract
IgA nephropathy is the world's most common primary glomerulonephropathy. Recent evidence in a rat model implicated excessive production of oxygen-free radicals in the pathogenesis and suggested that vitamin E-treatment ameliorated progression. We studied this antioxidant therapy on the glomerular filtration rate (GFR), proteinuria and hematuria in biopsy-proven IgA nephropathy in children. The duration of treatment or placebo was 2 years, with vitamin E treatment consisting of 400 IU/day in children weighing 30 kg. We measured GFR at entry, midpoint and exit. At baseline and at 4-month intervals after randomization, urinary protein/creatinine ratios and urinalysis were examined. The mixed model procedure with log transformation was used in data analysis to test treatment difference as well as the potential time effect. Fifty-five patients were randomized and 38 completed at least 1 year of follow-up. At entry, the clinical characteristics were not different between the treatment and placebo groups. There was a trend toward better preservation of GFR in vitamin E-treated versus placebo patients, 127±50 vs. 112±31 ml/min/1.73 m2, respectively (P=0.09). The urinary protein/creatinine ratio was significantly lower in the vitamin E-treated group vs. placebo; 0.24±0.38 vs. 0.61±1.37 (P<0.013). However, there was no difference in the prevalence of hematuria between the groups. Vitamin E treatment in our study patients was associated with significantly lower proteinuria, but no effect on hematuria. While there was a trend toward stabilization of GFR in the vitamin E-treated patients, long-term treatment and follow-up are needed to determine whether antioxidant therapy is associated with preservation of renal function in IgA nephropathy.Keywords
This publication has 24 references indexed in Scilit:
- Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio.2001
- Molecular Analysis of Urine Sediment for Follow-up of Urinary Tract CancersJNCI: Journal of the National Cancer Institute, 2000
- Executive summary. United States Renal Data System 1999 Annual Data Report.1999
- Influence of α-tocopherol over the time course of experimental IgA nephropathyPediatric Nephrology, 1999
- Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment.1997
- Vitamin E Ameliorates Renal Injury in an Experimental Model of Immunoglobulin A Nephropathy1Pediatric Research, 1996
- Evaluation of Serum and Tissue Levels of α-TocopherolBiochemical and Molecular Medicine, 1996
- IgA nephropathy: Long-term prognosis for pediatric patientsThe Journal of Pediatrics, 1995
- Diagnostic workup of renal disordersCurrent Problems in Pediatrics, 1991
- Glomerular Filtration Rate in Children with Advanced Chronic Renal Failure: Methods of Determination and Clinical ApplicationsAmerican Journal of Nephrology, 1982